Close Menu

NEW YORK – OpGen announced on Wednesday a preliminary 19 percent revenue increase for 2019 to $3.5 million from $3 million in 2018.

Revenue from the company's Acuitas AMR Gene Panel and Acuitas Lighthouse increased 147 percent to approximately $1.4 million, and preliminary operating loss was approximately $12.4 million, down 7 percent from $13.4 million in 2018. OpGen said it will announce its full-year and fourth quarter financial results in March.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.